Hyperkalemia burden and treatment patterns in Chinese patients on hemodialysis: final analysis of a prospective multicenter cohort study (PRECEDE-K).
中國透析患者高鉀血症的負擔與治療模式:前瞻性多中心隊列研究(PRECEDE-K)的最終分析。
Ren Fail 2024-09-10
Patiromer Treatment in Patients With CKD, Hyperkalemia, and Hyperphosphatemia: A Post Hoc Analysis of 3 Clinical Trials.
慢性腎臟病、高鉀血症和高磷血症患者的Patiromer治療:三項臨床試驗的事後分析。
Am J Kidney Dis 2023-11-16
Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up.
腎功能衰竭4-5期老年人血清鉀和死亡或腎臟替代治療風險:八年追蹤研究。
Am J Kidney Dis 2023-08-30
Novel Therapies in Diabetic Kidney Disease and Risk of Hyperkalemia: A Review of the Evidence From Clinical Trials.
糖尿病腎病的新療法及高鉀風險:臨床試驗證據回顧。
Am J Kidney Dis 2023-12-13
Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: smoking as a driver of hyperkalemia in men.
慢性腎臟病患者高鉀血症的性別特定風險因子和結果:吸菸作為男性高鉀血症的推手。
Clin Kidney J 2024-01-09
Real-world management of chronic and postprandial hyperkalemia in CKD patients treated with patiromer: a single-center retrospective study.
慢性腎臟病患者接受帕替麥酸鈉治療的慢性和進餐後高鉀血症的實際管理:單中心回顧性研究。
J Nephrol 2024-02-06
Management of Hyperkalemia in RAASi: Strategies to Maintain Chronic Kidney Disease Patients with Type II Diabetes on Therapy.
RAASi治療下高鉀血症的管理:維持患有II型糖尿病慢性腎病患者的治療策略。
Cardiorenal Med 2024-03-21
Maintained renin-angiotensin-aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study.
使用氯化鋯鈉環矽酸鹽在高鉀血症發作後維持腎素-血管緊張素-醛固酮系統抑制劑治療:多國群體研究。
Clin Kidney J 2024-05-03
Clinical Characteristics and Outcomes of Hyperphosphatemia in patients with CKD Stages 1 to 2.
慢性腎病第1至第2期患者高磷血症的臨床特徵及結果。
Kidney Blood Press Res 2024-07-24
The effect of dietary fiber on hyperkalemia in maintenance hemodialysis patients: a cross-sectional study.
飲食纖維對維持性血液透析患者高鉀血症的影響:一項橫斷面研究。
J Ren Nutr 2024-07-29